Clinical Trials Data Analysis Hepatic Encephalopathy

Natural History of Patients Taking Rifaximin-α for Recurrent Hepatic Encephalopathy and Risk of Future Overt Episodes and Mortality: A Post-hoc Analysis of Clinical Trials Data

https://dx.doi.org/10.1016/j.clinthera.2016.03.033

Post author By Bannister Ch A, Orr J G, Reynolds A V, Hudson M, Conway P, Radwan A, Morgan C L and Currie C J
Post date 28 April 2016

Bannister Ch A, Orr J G, Reynolds A V, Hudson M, Conway P, Radwan A, Morgan C L, Currie C J. 29 Apr 2016

Bannister Ch A

Orr J G

Reynolds A V

Hudson M

Conway P

Radwan A

Morgan C L

Currie C J

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Site by Create Summit